
Arpad Fabian-kovacs
Examiner (ID: 16444)
Most Active Art Unit | 3671 |
Art Unit(s) | 3616, 3671 |
Total Applications | 3046 |
Issued Applications | 2528 |
Pending Applications | 99 |
Abandoned Applications | 392 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10353513
[patent_doc_number] => 20150238519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'THERAPY FOR DRUG RESISTANT CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/626852
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11054
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626852
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/626852 | THERAPY FOR DRUG RESISTANT CANCER | Feb 18, 2015 | Abandoned |
Array
(
[id] => 11336932
[patent_doc_number] => 20160362688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'COMPOSITIONS AND METHODS OF USING MICRORNA INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/114128
[patent_app_country] => US
[patent_app_date] => 2015-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21897
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114128
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/114128 | COMPOSITIONS AND METHODS OF USING MICRORNA INHIBITORS | Feb 11, 2015 | Abandoned |
Array
(
[id] => 10430568
[patent_doc_number] => 20150315579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION'
[patent_app_type] => utility
[patent_app_number] => 14/616595
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48588
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14616595
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/616595 | DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION | Feb 5, 2015 | Abandoned |
Array
(
[id] => 10299158
[patent_doc_number] => 20150184157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'MODULATION OF TRANSTHYRETIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/614647
[patent_app_country] => US
[patent_app_date] => 2015-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18604
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14614647
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/614647 | MODULATION OF TRANSTHYRETIN EXPRESSION | Feb 4, 2015 | Abandoned |
Array
(
[id] => 10340714
[patent_doc_number] => 20150225720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma'
[patent_app_type] => utility
[patent_app_number] => 14/615144
[patent_app_country] => US
[patent_app_date] => 2015-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8547
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14615144
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/615144 | RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma | Feb 4, 2015 | Abandoned |
Array
(
[id] => 10980352
[patent_doc_number] => 20160177296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS'
[patent_app_type] => utility
[patent_app_number] => 14/604252
[patent_app_country] => US
[patent_app_date] => 2015-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25811
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604252
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/604252 | E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS | Jan 22, 2015 | Abandoned |
Array
(
[id] => 11270800
[patent_doc_number] => 20160333346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI'
[patent_app_type] => utility
[patent_app_number] => 15/111704
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24336
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111704
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/111704 | NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI | Jan 15, 2015 | Abandoned |
Array
(
[id] => 11312065
[patent_doc_number] => 20160348175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'A METHOD OF IDENTIFYING A NEONATE AT RISK OF HAVING OR DEVELOPING HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE)'
[patent_app_type] => utility
[patent_app_number] => 15/112036
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8085
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112036
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/112036 | A METHOD OF IDENTIFYING A NEONATE AT RISK OF HAVING OR DEVELOPING HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE) | Jan 15, 2015 | Abandoned |
Array
(
[id] => 10347835
[patent_doc_number] => 20150232841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHODS FOR USE IN MODULATING MIR-122A'
[patent_app_type] => utility
[patent_app_number] => 14/596822
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28047
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14596822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/596822 | Methods for use in modulating miR-122A | Jan 13, 2015 | Issued |
Array
(
[id] => 10444853
[patent_doc_number] => 20150329866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'NOVEL siRNAS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/592386
[patent_app_country] => US
[patent_app_date] => 2015-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30505
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592386
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/592386 | Methods of treating ischemia-reperfusion injury with siRNAs | Jan 7, 2015 | Issued |
Array
(
[id] => 14762459
[patent_doc_number] => 10392617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => miR-122* as an active micro-RNA, compositions comprising the same and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/109879
[patent_app_country] => US
[patent_app_date] => 2015-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 34
[patent_no_of_words] => 15952
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/109879 | miR-122* as an active micro-RNA, compositions comprising the same and uses thereof | Jan 5, 2015 | Issued |
Array
(
[id] => 11122309
[patent_doc_number] => 20160319282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'ARTIFICIAL MATCH-TYPE miRNA FOR CONTROLLING GENE EXPRESSION AND USE THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 15/108453
[patent_app_country] => US
[patent_app_date] => 2014-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17386
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108453
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108453 | Artificial match-type miRNA for controlling gene expression and use therefor | Dec 26, 2014 | Issued |
Array
(
[id] => 15727193
[patent_doc_number] => 10612020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Artificial mimic miRNA for controlling gene expression, and use of same
[patent_app_type] => utility
[patent_app_number] => 15/106958
[patent_app_country] => US
[patent_app_date] => 2014-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 11958
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 309
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106958
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106958 | Artificial mimic miRNA for controlling gene expression, and use of same | Dec 25, 2014 | Issued |
Array
(
[id] => 11115253
[patent_doc_number] => 20160312226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/105925
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16459
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105925 | Reduction of lipase activity in product formulations | Dec 17, 2014 | Issued |
Array
(
[id] => 11107989
[patent_doc_number] => 20160304959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING DIABETIC NEPHROPATHY'
[patent_app_type] => utility
[patent_app_number] => 15/104870
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24355
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104870
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104870 | COMPOSITIONS AND METHODS FOR TREATING DIABETIC NEPHROPATHY | Dec 15, 2014 | Abandoned |
Array
(
[id] => 11115248
[patent_doc_number] => 20160312221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'NON-CODED RNA OF IN-VIVO INFECTED MICROORGANISMS, PARASITIC MICROORGANISMS, SYMBIOTIC MICROORGANISMS AND IDENTIFICATION AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/103021
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12797
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103021
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103021 | Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same | Dec 8, 2014 | Issued |
Array
(
[id] => 10202708
[patent_doc_number] => 20150087696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS'
[patent_app_type] => utility
[patent_app_number] => 14/558229
[patent_app_country] => US
[patent_app_date] => 2014-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7689
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14558229
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/558229 | METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS | Dec 1, 2014 | Abandoned |
Array
(
[id] => 11963847
[patent_doc_number] => 20170268000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'ANTISENSE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/039188
[patent_app_country] => US
[patent_app_date] => 2014-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31475
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039188
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039188 | ANTISENSE COMPOUNDS AND USES THEREOF | Dec 1, 2014 | Abandoned |
Array
(
[id] => 13675855
[patent_doc_number] => 20160376661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => A METHOD FOR PREDICTING RESPONSIVENESS TO A TREATMENT WITH AN EGFR INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/038826
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038826 | A METHOD FOR PREDICTING RESPONSIVENESS TO A TREATMENT WITH AN EGFR INHIBITOR | Nov 25, 2014 | Abandoned |
Array
(
[id] => 11092710
[patent_doc_number] => 20160289678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/038124
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038124 | USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS | Nov 23, 2014 | Abandoned |